- NZ$2.33bn
- NZ$3.92bn
- NZ$855.59m
Annual balance sheet for Ryman Healthcare, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | R2024 March 31st | R2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 28.3 | 27.9 | 41.8 | 17.7 | 9.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 671 | 719 | 155 | 140 | 142 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,091 | 2,205 | 1,135 | 1,020 | 1,099 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Other Assets | |||||
| Total Assets | 10,966 | 12,511 | 11,904 | 11,986 | 12,266 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7,532 | 7,847 | 8,157 | 7,802 | 8,189 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 3,435 | 4,664 | 3,746 | 4,184 | 4,078 |
| Total Liabilities & Shareholders' Equity | 10,966 | 12,511 | 11,904 | 11,986 | 12,266 |
| Total Common Shares Outstanding |